CHA2DS2-VASc Bleed Calculator
Calculate cha2ds2vasc bleedcalculator quickly with our cardiovascular system tool. Get results based on evidence-based formulas with clear explanations.
Reviewed by Rahul Singh, Health & Wellness Specialist
Formula
HAS-BLED = H + A + S + B + L + E + D (each 0 or 1, max 9)
H = Hypertension (uncontrolled, SBP >160), A = Abnormal renal AND/OR liver function (1 point each), S = Stroke history, B = Bleeding history or predisposition, L = Labile INR (TTR <60%), E = Elderly (age >65), D = Drugs (antiplatelets/NSAIDs) AND/OR alcohol excess (1 point each). Score ranges from 0-9, with 3 or higher indicating high bleeding risk.
Worked Examples
Example 1: Low Bleeding Risk Patient
Problem:A 58-year-old patient with atrial fibrillation has well-controlled hypertension, no renal or liver disease, no prior stroke or bleeding, stable INR, and does not use NSAIDs or alcohol excessively.
Solution:Hypertension (controlled): 0 points (uncontrolled SBP >160 required)\nAbnormal renal function: 0\nAbnormal liver function: 0\nStroke history: 0\nBleeding history: 0\nLabile INR: 0\nAge >65: 0 (patient is 58)\nDrugs: 0\nAlcohol: 0\nTotal HAS-BLED Score = 0
Result:HAS-BLED: 0 (Low Risk, ~1.13% annual major bleeding rate)
Example 2: High Bleeding Risk Patient
Problem:A 72-year-old patient with uncontrolled hypertension, chronic kidney disease (creatinine 2.5 mg/dL), prior GI bleed, labile INR on warfarin, and daily aspirin use.
Solution:Hypertension (uncontrolled): +1\nAbnormal renal function: +1\nAbnormal liver function: 0\nStroke history: 0\nBleeding history (prior GI bleed): +1\nLabile INR: +1\nAge >65 (age 72): +1\nDrugs (aspirin): +1\nAlcohol: 0\nTotal HAS-BLED Score = 6
Result:HAS-BLED: 6 (High Risk, ~12.5% annual major bleeding rate). Address modifiable factors: control BP, switch warfarin to DOAC, discontinue aspirin if possible.
Frequently Asked Questions
What is the relationship between HAS-BLED and CHA2DS2-VASc scores?
The HAS-BLED and CHA2DS2-VASc scores are complementary tools used together in atrial fibrillation management. CHA2DS2-VASc assesses stroke risk to determine whether anticoagulation is indicated, while HAS-BLED assesses bleeding risk to guide monitoring intensity and risk factor modification. Several risk factors overlap between the scores, including hypertension, stroke history, and advanced age, meaning patients with high stroke risk often also have elevated bleeding risk. The clinical decision framework uses CHA2DS2-VASc first to establish indication for anticoagulation (score of 2 or higher in men, 3 or higher in women), then applies HAS-BLED to identify bleeding risks that need attention. Research consistently shows that for most patients, the net clinical benefit favors anticoagulation even when both scores are elevated.
References
- Pisters R, et al. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding. Chest. 2010;138(5):1093-1100.
- ESC Guidelines for the management of atrial fibrillation. European Heart Journal. 2020;42(5):373-498.
- Lip GYH. Implications of the CHA2DS2-VASc and HAS-BLED Scores. Thromb Haemost. 2011;106(3):528-538.
Reviewed by Rahul Singh, Health & Wellness Specialist · Editorial policy